bf/NASDAQ:GBT_icon.jpeg

NASDAQ:GBT

Global Blood Therapeutics, Inc.

  • Stock

USD

Last Close

68.48

04/10 20:00

Volume Today

3.28M

Avg: -

PE Ratio

−27.41

PFCF: -

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-18.12M
-
-20.81M
14.85%
-46.36M
122.81%
-82.47M
77.89%
-117.02M
41.90%
-174.19M
48.85%
-266.77M
53.14%
-247.55M
7.20%
-303.09M
22.43%
depreciation and amortization
534K
-
666K
24.72%
873K
31.08%
1.24M
41.47%
1.66M
34.25%
4.61M
177.86%
9.93M
115.58%
10.82M
8.97%
8.62M
20.39%
deferred income tax
stock based compensation
138K
-
350K
153.62%
3.22M
820.86%
9.23M
186.53%
13.68M
48.15%
30.08M
119.85%
45.65M
51.77%
71.48M
56.57%
78.67M
10.06%
change in working capital
289K
-
-627K
316.96%
6.85M
1,192.34%
4.28M
37.58%
7.96M
86.15%
4.75M
40.35%
27.08M
470.49%
-47.27M
274.54%
-42.44M
10.22%
accounts receivables
-2.64M
-
-14.86M
463.63%
-11.30M
23.97%
inventory
-1.28M
-
-36.78M
2,780.11%
-16.15M
56.09%
accounts payables
-465K
-
-304K
34.62%
2.71M
989.80%
1.07M
60.59%
2.77M
159.94%
-1.28M
146.37%
4.50M
450.12%
8.37M
86.13%
-3.72M
144.45%
other working capital
754K
-
-323K
142.84%
4.14M
1,382.97%
3.21M
22.56%
5.19M
61.64%
6.03M
16.29%
26.50M
339.26%
-4.00M
115.09%
-11.27M
181.72%
other non cash items
2.46M
-
297K
87.90%
4.53M
1,423.57%
704K
-
-616K
187.50%
-10.31M
1,574.51%
658K
106.38%
1.43M
117.02%
net cash provided by operating activities
-14.70M
-
-20.12M
36.88%
-30.89M
53.52%
-67.72M
119.24%
-93.02M
37.36%
-135.38M
45.53%
-194.42M
43.61%
-211.86M
8.97%
-256.81M
21.22%
investments in property plant and equipment
-940K
-
-323K
65.64%
-993K
207.43%
-1.35M
36.15%
-3.10M
129.36%
-4.82M
55.56%
-3.46M
28.28%
-8.75M
153.01%
-3.23M
63.07%
acquisitions net
purchases of investments
-105.50M
-
-127.72M
21.07%
-361.40M
182.96%
-434.92M
20.34%
-57.94M
86.68%
-50.35M
13.09%
sales maturities of investments
96.01M
-
182.00M
89.56%
361.47M
98.61%
384.00M
6.23%
65.70M
82.89%
other investing activites
-60K
-
-1.09M
-
75K
106.88%
45K
40%
net cash used for investing activites
-940K
-
-383K
59.26%
-993K
159.27%
-106.85M
10,660.52%
-35.91M
66.40%
-184.16M
412.89%
-76.86M
58.26%
317.31M
512.84%
12.11M
96.18%
debt repayment
common stock issued
43K
-
128.34M
-
117.00M
8.84%
231.96M
98.26%
396.50M
70.94%
219.44M
44.66%
46.14M
-
common stock repurchased
-67K
-
-90K
34.33%
-421K
367.78%
-12K
97.15%
dividends paid
other financing activites
15.24M
-
69.30M
354.81%
45K
99.94%
1.24M
2,655.56%
3.65M
194.68%
1.42M
61.22%
78.72M
5,455.05%
87.12M
10.68%
388.19M
345.58%
net cash used provided by financing activities
15.28M
-
69.30M
353.53%
128.32M
85.17%
118.14M
7.93%
235.19M
99.07%
397.91M
69.19%
298.16M
25.07%
87.12M
70.78%
434.33M
398.55%
effect of forex changes on cash
319K
-
net change in cash
-361K
-
48.79M
13,615.51%
96.43M
97.65%
-56.43M
158.52%
106.26M
288.30%
78.37M
26.24%
26.88M
65.70%
192.57M
616.41%
189.95M
1.36%
cash at beginning of period
3.64M
-
3.28M
9.92%
52.07M
1,488.44%
148.50M
185.20%
92.07M
38.00%
199.38M
116.55%
277.75M
39.31%
304.63M
9.68%
497.20M
63.21%
cash at end of period
3.28M
-
52.07M
1,488.44%
148.50M
185.20%
92.07M
38.00%
198.33M
115.41%
277.75M
40.04%
304.63M
9.68%
497.20M
63.21%
687.15M
38.20%
operating cash flow
-14.70M
-
-20.12M
36.88%
-30.89M
53.52%
-67.72M
119.24%
-93.02M
37.36%
-135.38M
45.53%
-194.42M
43.61%
-211.86M
8.97%
-256.81M
21.22%
capital expenditure
-940K
-
-323K
65.64%
-993K
207.43%
-1.35M
36.15%
-3.10M
129.36%
-4.82M
55.56%
-3.46M
28.28%
-8.75M
153.01%
-3.23M
63.07%
free cash flow
-15.64M
-
-20.44M
30.72%
-31.88M
55.95%
-69.08M
116.65%
-96.12M
39.16%
-140.20M
45.85%
-197.88M
41.14%
-220.62M
11.49%
-260.05M
17.87%

All numbers in USD (except ratios and percentages)